Clinical evaluation of the European LeukemiaNet response criteria in patients with essential thrombocythemia treated with anagrelide-Reference-Cited by-同舟云学术

Clinical evaluation of the European LeukemiaNet response criteria in patients with essential thrombocythemia treated with anagrelide

Published:2013-01-26 Issue:6 Volume:92 Page:771-775
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Hernández-Boluda Juan Carlos, ,Pereira Arturo,Cervantes Francisco,Gómez Montse,Arellano-Rodrigo Eduardo,Alvarez-Larrán Alberto,Ferrer-Marín Francisca,Kerguelen Ana,Márquez José Antonio,Antelo María Luisa,Besses Carles

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-013-1683-7.pdf

Reference11 articles.

1. Durie BG, Harousseau JL, Miguel JS et al (2006) International uniform response criteria for multiple myeloma. Leukemia 20(9):1467–1473

2. Cheson BD, Bennett JM, Kopecky KJ et al (2003) Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 21(24):4642–4649

3. Baccarani M, Cortes J, Pane F et al (2009) Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 27(35):6041–6051

4. Barosi G, Birgegard G, Finazzi G et al (2009) Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference. Blood 113(20):4829–4833

5. Hernandez-Boluda JC, Alvarez-Larran A, Gomez M et al (2011) Clinical evaluation of the European LeukaemiaNet criteria for clinicohaematological response and resistance/intolerance to hydroxycarbamide in essential thrombocythaemia. Br J Haematol 152(1):81–88

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloproliferative neoplasms in the adolescent and young adult population: A comprehensive review of the literature;British Journal of Haematology;2024-06-10

2. Essential thrombocythaemia: A contemporary approach with new drugs on the horizon;British Journal of Haematology;2024-04-08

3. Cytoreduction for ET and PV: who, what, when, and how?;Hematology;2023-12-08

4. Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera;Expert Review of Hematology;2023-04-05

5. Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia;Current Hematologic Malignancy Reports;2022-08-06